Does surgical and interventional correction of mitral valve regurgitation provide clinical and prognostic benefit in high-risk patients?
This ESC position statement highlights the need for randomized studies to clarify the clinical and prognostic benefits of correcting mitral regurgitation in high-risk patients.
Randomized studies are needed to clarify whether correction of MR in high-risk patients provides clinical and prognostic benefit in comparison with
Bonis et al. (Tue,) studied this question.